Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Timber Pharmaceuticals to be Acquired by LEO Pharma
Monday, August 21, 2023Timber Pharmaceuticals Inc Timber or the Company NYSE American TMBR today announced that it has entered into a definitive agreement to be acquired by LEO US Holding Inc LEO Pharma a whollyowned subsidiary of LEO Pharma AS in a total transaction value...
AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults
Monday, August 21, 2023AbbVie NYSE ABBV today announced that the European Commission has approved AQUIPTA atogepant for the prophylaxis of migraine in adults who have four or more migraine days per month The approval makes AQUIPTA the first and only oncedaily oral calciton...
European Commission Approves Reduced Dosing Frequency for Janssen’s Bispecific Antibody TECVAYLI
Saturday, August 19, 2023Teclistamab the first BCMAtargeting bispecific antibody to receive approval in Europe maintained deep and durable responses with reduced onset of Grade or higher infections in eligible patients with relapsed and refractory multiple myeloma RRMM swit...
Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Friday, August 18, 2023Immunic Inc Nasdaq IMUX a biotechnology company developing a clinical pipeline of orally administered small molecule therapies for chronic inflammatory and autoimmune diseases today announced the completion of enrollment of its phase CALLIPER trial...
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
Wednesday, August 16, 2023HDL Therapeutics Inc HDL Therapeutics a privately held commercial stage biotech company with an FDAapproved cardiovascular therapy the Plasma Delipidation System PDS System for reducing coronary atheroma in patients with homozygous familial hyperchol...
Valneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidate
Wednesday, August 16, 2023Valneva SE Nasdaq VALN Euronext Paris VLA a specialty vaccine company today announced that the US Food and Drug Administration FDA has revised the Prescription Drug User Fee Act PDUFA action date for the Biologics License Application BLA for VLA Valn...
XNK Therapeutics enters into agreement with US-based biotechnology company
Friday, August 11, 2023XNK Therapeutics AB XNK today announced that the company has entered into an agreement with a US biotechnology company Under the agreement the parties will perform preclinical evaluation of XNKs autologous NK cell therapy candidate XNK in combination...
Astex Expands Drug Discovery Collaboration With MSD
Thursday, August 10, 2023Astex Pharmaceuticals UK Astex a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system today announced an exclusive worldwide research collaborat...
RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
Wednesday, August 09, 2023RespireRx Pharmaceuticals Inc OTC Pink Market RSPI RespireRx focused on the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling and ResolutionRx Ltd ResolutionRx an unlist...
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
Tuesday, August 08, 2023Amarin Corporation plc NASDAQAMRN and Neopharm Israel announced today that the two companies have entered into an exclusive marketing and commercialization agreement for VAZKEPA icosapent ethyl in the State of Israel Gaza West Bank and the territorie...
